Alternatives to Zealthy

A high-disclosure program with clean async onboarding and both molecules nationwide — you pay more, but the price and the process are legible.

The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.

The familiar app-first pick, via its Hers side: a fast, polished async funnel and a flat, posted semaglutide price — dependable, if you can tune out the catalog of everything-else it wants to sell you.

A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included partner if you can live with a yearly plan and a pharmacy it doesn't name.

The clinician-forward option: flat pricing on both molecules and a program built around provider check-ins. You pay up and wait a touch longer for a more supervised, hand-held start.

The habit-plus-medication route: Noom bolts a prescriber onto its behavior-change app and will chase brand-name coverage through insurance. Powerful if you want coaching, but the true monthly is hard to pin down before you're in.

Injection or sublingual, both molecules — but we list it only with full disclosure: a 2025 FDA warning letter and a BBB complaint pattern around surprise 3-month charges make cancellation the real risk here.

The insurance-and-brand heavyweight: a membership that routes you toward FDA-approved product and coverage, with a required video visit. The slowest, most involved path here — and the right one if brand access is the whole point.